PRESS RELEASE published on 01/28/2026 at 15:45, 1 month 6 days ago Form 8.3 - The Vanguard Group, Inc.: Rio Tinto plc and Rio Tinto Limited The Vanguard Group, Inc. discloses a 4.46% stake in Rio Tinto plc and a 6.81% stake in Rio Tinto Limited. Additional interests in Glencore plc Vanguard Group Stake Disclosure Glencore Plc Rio Tinto Plc Rio Tinto Limited
BRIEF published on 01/27/2026 at 16:02, 1 month 7 days ago The Vanguard Group Discloses Position in Rio Tinto Shares Disclosure Takeover Code Vanguard Group Rio Tinto
BRIEF published on 01/27/2026 at 16:02, 1 month 7 days ago Le groupe Vanguard révèle sa position dans Rio Tinto Actions Groupe Vanguard Code De Prise De Contrôle Divulgation Rio Tinto
PRESS RELEASE published on 01/27/2026 at 15:57, 1 month 7 days ago Form 8.3 - The Vanguard Group, Inc.: Rio Tinto plc and Rio Tinto Limited The Vanguard Group, Inc. discloses 4.46% stake in Rio Tinto plc and 6.80% in Rio Tinto Limited as of 26 Jan 2026. Cash-settled derivatives and transactions detailed Vanguard Group Stake Disclosure Cash-settled Derivatives Rio Tinto Plc Rio Tinto Limited
BRIEF published on 01/26/2026 at 16:03, 1 month 8 days ago Vanguard révèle d'importantes participations dans Rio Tinto Groupe Vanguard Investissement Dans Le Secteur Minier Code Des OPA Britannique Déclaration Du Formulaire 8.3 Les Participations De Rio Tinto
BRIEF published on 01/26/2026 at 16:03, 1 month 8 days ago Vanguard Discloses Significant Rio Tinto Holdings Vanguard Group Form 8.3 Disclosure UK Takeover Code Rio Tinto Holdings Mining Sector Investment
PRESS RELEASE published on 01/26/2026 at 15:58, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Rio Tinto plc and Rio Tinto Limited The Vanguard Group, Inc. discloses 4.46% interest in Rio Tinto plc and 6.80% in Rio Tinto Limited through Form 8.3 submission Form 8.3 Disclosure The Vanguard Group Rio Tinto Plc Rio Tinto Limited
BRIEF published on 01/23/2026 at 15:45, 1 month 11 days ago Le groupe Vanguard révèle sa participation dans Rio Tinto Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Rio Tinto Information Sur Les Investissements
BRIEF published on 01/23/2026 at 15:45, 1 month 11 days ago Vanguard Group Discloses Stake in Rio Tinto Form 8.3 Takeover Code Vanguard Group Investment Disclosure Rio Tinto
PRESS RELEASE published on 01/23/2026 at 15:40, 1 month 11 days ago Form 8.3 - The Vanguard Group, Inc.: Rio Tinto plc and Rio Tinto Limited The Vanguard Group, Inc. discloses 4.45% stake in Rio Tinto plc and 6.80% stake in Rio Tinto Limited as of 22 Jan 2026. Also making disclosures related to Glencore plc The Vanguard Group, Inc. Stake Disclosure Glencore Plc Rio Tinto Plc Rio Tinto Limited
Published on 03/03/2026 at 22:30, 8 hours 43 minutes ago Sparta Capital Ltd Releases Q1 Financial Results
Published on 03/03/2026 at 19:40, 11 hours 33 minutes ago NRCan Awards Nano One $3M To Support LFP Cathode Material Supply Chain Initiative
Published on 03/03/2026 at 19:40, 11 hours 33 minutes ago RNCan octroie 3 M$ à Nano One pour soutenir la chaîne d'approvisionnement des matériaux cathodes LFP
Published on 03/03/2026 at 17:00, 14 hours 13 minutes ago MWC 2026: Vodafone Germany Multi-Year Transformation Reaches Commercial Launch with Amdocs
Published on 03/03/2026 at 15:00, 16 hours 13 minutes ago Star Copper Announces Upsize To Flow Through Financing
Published on 03/04/2026 at 07:03, 9 minutes ago EQS-Adhoc: adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board
Published on 03/04/2026 at 07:00, 13 minutes ago BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy
Published on 03/04/2026 at 06:45, 28 minutes ago Anja Hendel, Max Müller and Peter Schmid von Linstow to be nominated to the Supervisory Board of Redcare Pharmacy.
Published on 03/04/2026 at 06:44, 28 minutes ago PALFINGER AG – THIRD-BEST FISCAL YEAR IN THE COMPANY'S HISTORY AND FOCUS ON PROFITABLE GROWTH
Published on 03/04/2026 at 06:30, 43 minutes ago Redcare Pharmacy: Strong growth in 2025 surpassing EUR 1bn in Rx revenue; adj. EBITDA up 72% yoy.
Published on 03/04/2026 at 07:02, 11 minutes ago TERACT - Availibility of the Half-year Financial Report As of 31 December 2025
Published on 03/04/2026 at 07:02, 11 minutes ago TERACT - Mise à disposition du Rapport Financier Semestriel au 31 décembre 2025
Published on 03/03/2026 at 18:09, 13 hours 3 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Février 2026
